Merck, Inc'

1
Merck, Inc.
Josie Gonzales Christina Kim Anthony Muhl Renato
Vinuya
2
Company Overview

• Leading global pharmaceutical company
• 11 Major research centers
• 32 Manufacturing facilities
• Produce and sell pharmaceuticals 150 Countries

3
Product Line Includes

• Drugs
• Vacines
• Respiratory
• Anti-Bacterial
• Anti-Fungal

4
Drugs Include

• Atherosclerosis
• Hypertension
• Heart Failure
• Osteoporosis
• Anti-Ulcerants
• Anti-Inflamitory
• HIV

5
Economic Indicators

• Policies
• Budgeting
• Designs
• Company Structure

6
Stock Option Plan 1999-2001

• 197,200.7 shares in 2001
• Average Price - 56.98
• Dividend Yield - 1.7
• Expected Life 6.7
• Average Common Shares Outstanding 2322.3
• (shares in thousands)

7
Top 5 Selling Drugs

• Zocor
• Vioxx
• Cozaar/Hyzaar
• Fosamax
• Singulair

8
Merck Stock Performance
9
Facts About GDP

• Total national health expenditures rose from 8.8
  of GDP in 1980 to 13.2 in 2002
• U.S.A. spends more money on healthcare as a
  percentage of GDP than any other industrialized
  nation
• Some governments are top buyers of medicine to
  negotiate better price. This delays medicines
  from reaching patients.

10
Healthcare as of GDP
11
Drug spending increased in 2000 14.7
12
Research Development

• Must find new drugs to replace ones where the
  patent expired
• New vaccines such as for use on AIDS
• Must compete with researchers around the world.

13
Thank You